RDL - In-House and Research Studies

RDL Stays Ahead with Research Studies

RDL Reference Laboratory spends the necessary resources for up to date research studies.

	Resource Center \| In-House and Research Studies

RDL works to provide the most helpful studies and research for health care professionals.

In-house study comparing the ability of newer generation anti-dsDNA ELISA assays to follow SLE disease activity relative to the Farr Assay.

Shen, G, et al, “RNA polymerase I/III autoantibodies in systemic sclerosis and different disease groups,” Clinical Chemistry, Vol. 51, No. 6 (Supplement), A89, 2005.

Shen, G, et al, “Anti-alpha-fodrin specific IgA antibodies in Sjogren’s Syndrome and other autoimmune diseases,” Clinical Chemistry, Vol. 51, No. 6 (Supplement), A121, 2005.

Wu, R, et al, “Elevated levels of autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine (oxPAPC) in patients with hypertension and myocardial infarction,” J Autoimmunity, Vol. 24, 349-56, 2005.

In-house study comparing the sensitivity and specificity of the third generation versus second generation anti-ccp assay in 540 Rheumatoid Arthritis, autoimmune disease group and normal control samples from our serum bank.

Hueber W, et al, “Proteomic analysis of secreted proteins in early rheumatoid arthritis: Anti-citrulline reactivity is associated with upregulation of proinflammatory cytokines,” Ann Rheum Dis published online 10 Aug 2006.

In-house study utilizing 1500 patient samples from our serum bank to compare the clinical utility of the commercially available bead-based autoimmune multiplex assays versus established methods (IFA, RIA and ELISA).

Shen, GQ, et al, “Anti-neuronal antibodies in CNS-SLE patients and other autoimmune diseases,” Arthritis & Rheumatism, Vol. 54, No. 9 (Supplement), S292-3, 2006.

Ishimori, ML, et al, “Screening for autoantibodies: the significance of ANA titer and its relationship to other autoantibodies,” Arthritis & Rheumatism, Vol. 54, No. 9 (Supplement), S441-2, 2006.